Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2021

FUROSCIX CRLs (scPharmaceuticals)

Presenter: Daniel Bensimhon

November 06, 2021

Presentation TCT 2021

AquaPass

Presenter: Doron Aronson

November 06, 2021

Presentation TCT 2021

Treating the Lymphatic System for Acute and Chronic HF

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

New Approaches to Diuresis - Reprieve

Presenter: Jeffrey Testani

November 06, 2021

Presentation TCT 2021

Manipulation of Renal Preload and Afterload for Acute Decompensated Heart Failure

Presenter: Navin Kapur

November 06, 2021

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Presentation TCT 2021

Indirect Annuloplasty Technology- Lessons Learned Over the Past Decade

Presenter: Samir Kapadia

November 06, 2021

Presentation TCT 2021

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

Presenter: Mir Basir

November 04, 2021

Presentation TCT 2021

TCT 538: Percutaneous Decommissioning of a HeartWare Left Ventricular Assist Device in a Patient With Myocardial Recovery

Presenter: Carey Kimmelstiel

November 04, 2021

Presentation TCT 2021

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

Presenter: Mohit Pahuja

November 04, 2021

Presentation TCT 2021

Debate 2: Con – The ISCHEMIA Results Apply to All Revascularization; We All Need to Reconsider Our Approach

Presenter: Sripal Bangalore

November 04, 2021

Presentation TCT 2021

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Presenter: Mario Gaudino

November 04, 2021

Presentation TCT 2021

Debate 1: Con – Anatomy First; NICE Guidelines Got It Right

Presenter: Nick Curzen

November 04, 2021

Presentation TCT 2021

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

Presenter: Raymond Kwong

November 04, 2021

Presentation TCT 2021

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Presenter: Christopher Rajkumar

November 04, 2021

Presentation TCT 2021

Quality of Life Matters to Patients: How ISCHEMIA and ORBITA Have Informed Our Practice

Presenter: Suzanne Arnold

November 04, 2021

Presentation TCT 2021

The ISCHEMIA Sub-studies: Highlights and Take-Home Messages

Presenter: David Maron

November 04, 2021

Presentation TVT 2021

Shared Decision Making for the Management of the TAVR Patient

Presenter: Megan Coylewright

July 20, 2021

Presentation TVT 2021

Hypertrophic Obstructive Cardiomyopathy

Presenter: Paul Sorajja

July 20, 2021

Presentation TVT 2021

Small Valve Area and Mitral Calcification

Presenter: Pradeep Yadav

July 20, 2021

Advertisement

FUROSCIX CRLs (scPharmaceuticals)

AquaPass

Treating the Lymphatic System for Acute and Chronic HF

New Approaches to Diuresis - Reprieve

Manipulation of Renal Preload and Afterload for Acute Decompensated Heart Failure

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Indirect Annuloplasty Technology- Lessons Learned Over the Past Decade

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

TCT 538: Percutaneous Decommissioning of a HeartWare Left Ventricular Assist Device in a Patient With Myocardial Recovery

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

Debate 2: Con – The ISCHEMIA Results Apply to All Revascularization; We All Need to Reconsider Our Approach

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Debate 1: Con – Anatomy First; NICE Guidelines Got It Right

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Quality of Life Matters to Patients: How ISCHEMIA and ORBITA Have Informed Our Practice

The ISCHEMIA Sub-studies: Highlights and Take-Home Messages

Shared Decision Making for the Management of the TAVR Patient

Hypertrophic Obstructive Cardiomyopathy

Small Valve Area and Mitral Calcification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content